Continuous Improvement & Updates Flashcards

A regulatory affairs professional is monitoring the Federal Register for rule changes. A final rule is published with a compliance date 18 months away. What is the FIRST step in an effective continuous improvement response?

Answer: Immediately perform a gap assessment to identify affected processes and products

Immediate gap assessment identifies all affected products, processes, and submissions so implementation planning can begin with adequate lead time.

Which metric is MOST useful for evaluating the effectiveness of a regulatory affairs continuous improvement program over time?

Answer: First-cycle approval rate for regulatory submissions

First-cycle approval rate directly measures whether process improvements are producing higher-quality submissions that gain approval without requests for additional information.

An FDA Warning Letter cites a company for failure to investigate consumer complaints that could indicate product adulteration. Under 21 CFR 211.198, what corrective action is most critical?

Answer: Establish a complaint trending and investigation system that triggers CAPA for potentially serious complaints

21 CFR 211.198 requires investigation of complaints that could indicate product failure, necessitating a robust system that identifies and investigates potentially serious complaints.

In the context of ICH Q8, 'design space' primarily facilitates continuous improvement by:

Answer: Allowing operational flexibility within proven acceptable ranges without requiring regulatory submissions

Movement within the approved design space is not considered a change requiring regulatory submission, enabling manufacturers to optimize processes without filing supplements.

A company wants to implement a Corrective Action to address recurring Out-of-Specification (OOS) results. Before closing the CAPA, which documentation is REQUIRED under 21 CFR 211.192?

Answer: Written record of the investigation including assignable cause and disposition decision

21 CFR 211.192 requires a written record of the laboratory investigation, including the cause of the OOS result if identified, and the disposition of the affected batch.

A medical device manufacturer receives multiple MDRs citing the same failure mode within 6 months. Under 21 CFR Part 803, what continuous improvement obligation is triggered?

Answer: Analyze the trend and consider whether a remedial action or recall is necessary

Recurring MDR events for the same failure mode require trend analysis to determine if a systemic corrective action, field safety corrective action, or recall is warranted.

During a process validation review under FDA's 2011 Guidance on Process Validation, Stage 3 (Continued Process Verification) is BEST described as:

Answer: Ongoing assurance during routine production that the process remains in a state of control

Stage 3 involves ongoing data collection and statistical analysis during routine production to ensure the validated process remains capable and in control.